Feasibility, safety, and efficacy of pediatric constraint-induced movement therapy for patients with upper extremity hemiparesis

Feasibility, safety, and efficacy of pediatric constraint-induced movement therapy for patients with upper extremity hemiparesis - Pediatric constraint-induced movement therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039715

Enrollment

Registered

2020-03-06

Start date

2019-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with upper extremity hemiparesis due to cerebral palsy, stroke, brain tumor and traumatic brain injury.

Interventions

Intervention Technique: CIMT Training Dose: more than 30 hours Training Period: 3 Months CIMT components: 1) constraining the patient to use the more-impaired UE, 2) repetitive, task-oriented

s real-world environment).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with cerebral palsy 1) Gross Motor Function Classification System: 1-3 2) Manual ability classification system: 1-4 Other patients 1) Possible to walk independently 2) Brunnstrom recovery stage: 3-6

Exclusion criteria

Exclusion criteria: 1) Unable to understand simple order 2) Uncontrolled complications 3) Unable to obtain informed consent

Design outcomes

Primary

Measure	Time frame
Outcome Measures 1) The feasibility of research protocol 2) Adverse events 3) Jebsen Taylor Test of Hand Function Test Assessment timing Outcome measures were assessed at baseline, after intervention, 1 month follow up, 6 months follow up and 12 months follow up. Statistical assessment Short-term effect: t test or Wilcoxon signed rank test Long-term effect: ANOVA or Kruskal-Wallis or Dunnet Tukey-Kramer,or Bonferroni method	—

Measure

Time frame

Outcome Measures 1) The feasibility of research protocol 2) Adverse events 3) Jebsen Taylor Test of Hand Function Test Assessment timing Outcome measures were assessed at baseline, after intervention, 1 month follow up, 6 months follow up and 12 months follow up. Statistical assessment Short-term effect: t test or Wilcoxon signed rank test Long-term effect: ANOVA or Kruskal-Wallis or Dunnet Tukey-Kramer,or Bonferroni method

—

Secondary

Measure	Time frame
(1) Fugl-Meyer Assessment (2) Pediatric Motor Activity Log-Revised Assessment timing Outcome measures were assessed at baseline, after intervention, 1 month follow up, 6 months follow up and 12 months follow up. Statistical assessment Short-term effect: t test or Wilcoxon signed rank test Long-term effect: ANOVA or Kruskal-Wallis or Dunnet Tukey-Kramer,or Bonferroni method	—

Countries

Japan

Contacts

Public ContactAtsushi Umeji

Hyogo college of medicine college hospital Department of physical medicine and rehabilitation

umejiume@hyo-med.ac.jp0798-45-6388

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026